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answers. A clustered multivariate regression analysis explored theoretical validity of 
results. RESULTS: On average, respondents are willing to pay a12,920 (VAS scores) 
and a24,549 for a QALY (EuroQoL tariffs). Subgroup analysis showed great variation 
in WTP/QALY between income groups—from a5,000 in the lowest to a87,000 for a 
QALY in the highest group. Respondents that indicated a high level of certainty 
exhibited marginally higher WTP. Regression analyses showed a consistent relation-
ship between income, other demographics and WTP/QALY. CONCLUSIONS: Indi-
vidual WTP/QALY should be seen as a step to a sound empirical value of the social 
cost-effectiveness threshold in the Netherlands. Estimates elicited in this study are 
similar to those found in other empirical studies and are systematically lower than 
often cited thresholds, largely unsupported by empirical evidence (i.e. $50,000). 
However, there is a wide gap between the social and private value of a QALY. Future 
research should move towards estimating the social value of the cost-effectiveness 
threshold and align with the perspective of decision-makers thus creating a truly valu-
able decision-making tool.
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OBJECTIVES: Innovative point-of-care diagnostics are likely to be having a strong 
impact on health care. The aim of this study is to conduct an early assessment of            
point-of-care chips. These chips can detect many particles and, consequently, many 
product-market combinations can be developed. This study investigates the impact of 
potential point-of-care applications in health care and to quantify the impact in terms 
of their likely cost-effectiveness. METHODS: The Analytic Hierarchy Process (AHP); 
a technique for multi-criteria analysis, and Markov modeling were applied in this early 
assessment. The AHP was used to prioritize six potentially attractive product-market 
combinations (PCM’s). For estimating the future cost-effectiveness of the most attrac-
tive PMC’s, Markov health state transition models were developed. Two Markov 
models were constructed; models for a potassium chip for both stage 5 CKD patients 
as well as heart failure (HF) patients which suffer from edemas. RESULTS: AHP 
identified clinical gain as being the most important criterion to assess the attractiveness 
of a PMC, followed by market potential, attitude of professionals, R&D barriers and 
implementation barriers. Regarding these criteria, a potassium-chip for Chronic 
Kidney Disease (CKD) and Heart Failure (HF) patients was calculated to be the most 
attractive alternative. Markov model cohort simulation yielded incremental cost-effec-
tiveness ratios (ICERs). The point-of-care chip appeared not to be cost-effective for 
preventing hyperkalemia in stage 5 CKD patients. For HF patients suffering from 
edemas the chip was estimated to be cost-effective and could provide a valuable asset 
to current treatment. CONCLUSIONS: The AHP is valuable in supporting the iden-
tification of potentially attractive product-market combinations. For the best combina-
tions, Markov modeling can subsequently provide a more in-depth analysis of the 
future cost-effectiveness.
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OBJECTIVES: At present the costs and effects of providing informal care are often 
ignored in economic evaluations. This is problematic since considering informal      
care a ‘zero cost’ substitute for formal care may result in non-optimal decisions from      
a societal perspective, at the burden of carers. This study further investigates 
the validity of the CarerQol instrument, which values the full impact of informal 
care on caregivers. The CarerQoL consists of seven burden dimensions (CarerQol-7D)      
and a visual analogue scale measuring happiness (CarerQol-VAS). METHODS: 
A questionnaire was distributed by mail among a sample of caregivers (n  1100) 
via regional support centres for informal caregivers throughout the Netherlands. 
Construct validity (n  249) was tested with Spearman’s correlation coefficients of        
the CarerQol-VAS and the CarerQol-7D and two measures of subjective burden 
and the utility of care giving. Clinical validity was evaluated by the multivariate cor-   
relation between the CarerQol-VAS and characteristics of the caregiver, care recipient 
and care situation. Differences in CarerQol-VAS scores among caregivers are explained 
with subgroup multiple linear regression analyses and principal component analyses. 
RESULTS: CarerQol-VAS scores were negatively associated with burden and posi-
tively with utility of caring. The seven dimensions of the CarerQol-7D were also 
associated with burden and utility of caring in the expected direction, for six dimen- 
sions the associations were statistically significantly. Significant associations with 
CarerQol-VAS scores were found for a range of characteristics, including duration 
and intensity of care, relationship between carer and patient, carer education level and 
patient age. CONCLUSIONS: Our results further support the construct and clinical 
validity of the CarerQol and thus underlines the relevance of this instrument 
for including informal care effects in economic evaluations. The next, necessary 
step in the development of the CarerQol concerns the establishment of tariffs for the             
caring situations defined by the seven dimensions. This is the topic of coming           
research.
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OBJECTIVES: To assess the provision of health care and reimbursement in ambula-
tory palliative care in Germany. METHODS: A survey was conducted among 1000 
office-based physicians in January 2009, covering e.g. the following topics: quantity 
of palliative care, its reimbursement and resource use due to side effects of opioid 
medication. RESULTS: A total of 314 physicians (30% response rate) were included 
in the statistical analysis. A total of 63.7% were general practitioners (GP), 36.3% 
specialists. A total of 67% of all physicians were additionally trained in palliative 
medicine. Fifty percent estimate efforts associated with palliative care to be at least 
1.5 times higher compared to patients with other serious conditions. On average GPs 
(specialists) visit palliative patients 5.9 (3.7) times per quarter at home (2.3 (1.2) visits 
for non-palliative though sick patients, p  0.01). Overall palliative patients also 
require more office consultations compared to nonpalliative patients (4.6 vs. 3.5, GP 
4.7 vs. 3.5, specialist 4.5 vs. 3.4, all p  0.01) and need more time per visit (17.5 min 
versus 11.5 min) (p  0.01). Constipation is the most frequent side-effect in opioid 
medication and requires app. 20% more time and effort compared to no constipation. 
According to the German Remuneration Scheme (EBM) GPs (specialists) receive a 
lump-sum per quarter for office consultations, irrespective of number or length of visit 
or palliative status, of app. a35 (31) and a mean of app. a7.50 (7) for a basic consulta-
tion. Hence, 95% (60%) of the participants trained in palliative care evaluate the 
reimbursement and health care structures in the German setting as insufficient or very 
insufficient. CONCLUSIONS: Compared to non-palliative there is a higher need for 
medical resources among palliative patients—a need that is currently not reflected in 
the remuneration system. Considering the demographic development and the resulting 
significance of palliative care further research should focus on identifying room for 
improvement and corresponding strategies.
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OBJECTIVES: To assess the prescription drug knowledge and the impact of counsel-
ing on it in patients visiting a public teaching hospital. METHODS: A standardized 
questionnaire of prescription drug knowledge that embraces 8 questions e.g. drug 
name, indication, side effect, dose, frequency of dosing, dosage schedule, storage and 
missed dose action of prescription drugs was used. Education level was set as group-1 
illiterate patients, group-2 education up to secondary school and group-3 graduate 
patients. The patients were scored 1 for every correct answer, with a maximum of 8. 
The overall scores were then categorized as low (3), medium (3–6) and high (6). 
Patients were counseled by oral, written, oral-pictorial combine, written-pictorial 
combine and oral-written-pictorial combine for all the questions. Post counseling 
evaluation was performed to assess the impact of patient counseling. RESULTS: Total 
753 patients were assessed. Patient’s knowledge about prescription drug name, side 
effect, dose and missed dose action was poor. The prescription drug knowledge score 
was low (3) in group-1 and the patients of acute drug treatment. Whereas, medium 
(3–6) knowledge score was observed in group-2, group-3 and patients of chronic drug 
treatment. The overall score was improved from 3.43 o 1.47 to 6.20   o 1.26 after  
counseling in all enrolled patients. After counseling overall score was improved from 
2.88 o 1.40 to 6.01   o 1.16 and from 3.71    o 1.43 to 6.30   o 1.29 in patients of acute     
and chronic drug treatment, successively. Improvement in overall score was observed 
from 2.78 o 1.37 to 5.55   o 1.19, from 3.52   o 1.10 to 6.32   o 0.88 and from 4.49    o 
1.55 to 7.25 o 1.17 in educational group-1, group-2 and group-3 after counseling,         
respectively. CONCLUSIONS: Patients having low level of education, acute drug 
treatment and especially female patients know little about their prescribed drugs. 
Patient counseling about their prescribed drugs will help to improve the patient’s 
compliance and may lead to achieve better patient outcome.
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OBJECTIVES: The purpose of the current study is to evaluate the pharmaceutical 
industries’ situation and the effective factors in pharmaceutical products exportation 
in successful exporting countries and to compare the results with the situation of 
pharmaceutical industries in Iran and the factors affecting their exportation experi-
ences. METHODS: For the purposes of current cross-sectional study, an analytic 
questionnaire with open ended questions was designed which consisted of 32 questions 
in 8 fields. Subjects of the study consisted of 20 experts and officeholders of pharma-
ceutical industries and pharmaceutical products exporting companies and relevant 
governmental sections. Relevant information regarding pharmaceutical industries and 
